Pharmaceutical companies warned European Commission President Ursula von der Leyen of a potential exodus to the US as tariffs ...

The United States emerged as the top nation with over 36 per cent share of India’s pharmaceutical exports at $9.8 billion for ...

The Indian pharmaceutical market (IPM) grew by 8.4 per cent in the financial year (FY) 2025 on the back of major therapies ...

As the impacts of Donald Trump’s tariffs continue to ripple through the world’s economies, one sector is nervously wondering ...

Pfizer's abnormally high yield seems more a symptom of all this negative sentiment than a red flag about the dividend's sustainability. Management just raised the quarterly dividend in December, and ...

European pharma companies warned the European Commission president in a meeting on Tuesday that U.S. President Donald Trump's ...

European pharma companies warned the European Commission president in a meeting on Tuesday that U.S. President Donald Trump's ...

RFK Jr supported the MMR vaccine’s efficacy in preventing measles, but also shared unproven treatment strategies.

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Sweeping tariffs imposed by President Donald Trump April 2 have triggered concern across the healthcare sector, particularly among hospitals and industry leaders, as they brace for cost increases and ...

The Trump Tariffs' Impact on the Indian Sector, from auto to IT, all the major exporting companies face challenges.

Although elevated after 2023 acquisitions, CVS’ financial position remains manageable, in our opinion, and investors should note that CVS intends to maintain a solid investment-grade credit rating.